Regal Investment Advisors’s Akoya BioSciences AKYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17,464
Closed -$40K 461
2024
Q4
$40K Sell
17,464
-265
-1% -$702 ﹤0.01% 464
2024
Q3
$48.2K Sell
17,729
-1,031
-5% -$2.52K ﹤0.01% 496
2024
Q2
$43.9K Buy
18,760
+7,340
+64% +$23.4K ﹤0.01% 567
2024
Q1
$53.6K Buy
11,420
+280
+3% +$1.45K ﹤0.01% 572
2023
Q4
$54.4K Buy
+11,140
New +$46.3K ﹤0.01% 533

Other funds holding AKYA

Regal Investment Advisors's AKYA Position: Q1 2025 in Review

Regal Investment Advisors sold out of Akoya BioSciences (AKYA) in Q1 2025, closing a stake of 17,464 shares — an estimated $40K sold.

Regal Investment Advisors first reported a position in AKYA in Q4 2023 and held it in 5 quarters. The position peaked at $54.4K in Q4 2023. 64 funds tracked by Wall St. Rank hold AKYA as of Q1 2025.

  • Regal Investment Advisors reported no remaining Akoya BioSciences position as of Q1 2025 after selling out during the quarter.
  • Regal Investment Advisors sold 17,464 Akoya BioSciences shares in Q1 2025, an estimated $40K.
  • Regal Investment Advisors first reported a position in Akoya BioSciences in Q4 2023 and held it in 5 quarters.
  • Regal Investment Advisors's Akoya BioSciences position peaked at $54.4K in Q4 2023.
  • 64 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2025.

Based on Regal Investment Advisors's 13F filing for Q1 2025, filed 12 May 2025.